COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 296 participants.

Also called NCT01925794

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 296 participants (enrolled count) (from the registry)
Sponsor
CeloNova BioSciences, Inc. (from the registry)
Registry
  • NCT NCT01925794
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, France, Germany, Latvia, Serbia, Spain, Switzerland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01925794. Allocation not applicable; no masking; primary purpose treatment. Start 2013-08-21 (registry gives no type); primary completion 2015-11 (actual). Results posted on 2021-12-22.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT
Intervention (Device)
COBRA PzF
Lead sponsor
CeloNova BioSciences, Inc. (class: industry)

Record details

Record id
cardio:ct-nct01925794
Content hash
bbd82eb8cbb225dfa131a076cf48da26bf1a726fe0f994763c4262530ab91f3f